Continue to site >
Trending ETFs

Health & Biotechnology Portfolio

mutual fund
SHPAX
Payout Change
Suspended
Price as of:
$20.15 +0.1 +0.5%
primary theme
Health Care Sector Equity
SHPAX (Mutual Fund)

Health & Biotechnology Portfolio

Payout Change
Suspended
Price as of:
$20.15 +0.1 +0.5%
primary theme
Health Care Sector Equity
SHPAX (Mutual Fund)

Health & Biotechnology Portfolio

Payout Change
Suspended
Price as of:
$20.15 +0.1 +0.5%
primary theme
Health Care Sector Equity

Name

As of 06/21/2024

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

$20.15

$12.1 M

0.00%

2.75%

Vitals

YTD Return

6.2%

1 yr return

10.6%

3 Yr Avg Return

4.3%

5 Yr Avg Return

8.9%

Net Assets

$12.1 M

Holdings in Top 10

41.6%

52 WEEK LOW AND HIGH

$20.1
N/A
N/A

Expenses

OPERATING FEES

Expense Ratio 2.75%

SALES FEES

Front Load 5.75%

Deferred Load N/A

TRADING FEES

Turnover 19.00%

Redemption Fee N/A


Min Investment

Standard (Taxable)

$250

IRA

N/A


Fund Classification

Fund Type

Open End Mutual Fund


Name

As of 06/21/2024

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

$20.15

$12.1 M

0.00%

2.75%

SHPAX - Profile

Distributions

  • YTD Total Return 6.2%
  • 3 Yr Annualized Total Return 4.3%
  • 5 Yr Annualized Total Return 8.9%
  • Capital Gain Distribution Frequency Annually
  • Net Income Ratio -1.08%
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency Annual

Fund Details

  • Legal Name
    Health & Biotechnology Portfolio
  • Fund Family Name
    Saratoga Advantage Trust
  • Inception Date
    Jan 28, 2003
  • Shares Outstanding
    N/A
  • Share Class
    A
  • Currency
    USD
  • Domiciled Country
    US
  • Manager
    Robert Stimpson

Fund Description

The Portfolio will normally invest at least 80% of its total assets in equity securities of U.S. and foreign healthcare companies and biotechnology companies, regardless of their stock market value (or “market capitalization”). Equity securities include common stocks, preferred stocks, securities convertible into common stocks and warrants. The Adviser utilizes a top-down investment approach focused on long-term economic trends. The Adviser begins with the overall outlook for the economy, then seeks to identify specific industries with attractive characteristics and long-term growth potential. Ultimately, the Adviser seeks to identify high-quality companies within the selected industries and to acquire them at attractive prices. The Adviser’s stock selection process is based on an analysis of individual companies’ fundamental values, such as earnings growth potential and the quality of corporate management.

Companies described as Health Care Equipment and Supplies, Health Care Provider Services, Pharmaceutical or Biotechnology Companies under the North American Industry Classification System are considered healthcare or biotechnology companies for purposes of investment by the Portfolio. These companies are principally engaged in: the design, manufacture or sale of products or services used for or in connection with health, medical, or personal care such as medical, dental and optical supplies or equipment; research and development of pharmaceutical products and services; the operation of healthcare facilities such as hospitals, clinical test laboratories and convalescent and mental healthcare facilities; and the design, manufacture, or sale of healthcare-related products and services, research, development, manufacture or distribution of products and services relating to human health care, pharmaceuticals, agricultural and veterinary applications and the environment; and manufacturing and/or distributing biotechnological and biomedical products, devices or instruments or provide materials, products or services to the foregoing companies.

Factors considered include growth potential, earnings, valuation, competitive advantages and management. When market or financial conditions warrant, the Portfolio may also make temporary investments in investment grade debt securities. Such investment strategies could result in the Portfolio not achieving its investment objective.

Read More

SHPAX - Performance

Return Ranking - Trailing

Period SHPAX Return Category Return Low Category Return High Rank in Category (%)
YTD 6.2% -25.7% 27.3% 61.73%
1 Yr 10.6% -25.7% 33.3% 50.62%
3 Yr 4.3%* -34.8% 14.2% 27.10%
5 Yr 8.9%* -6.6% 16.1% 45.65%
10 Yr 6.6%* -0.5% 13.3% 74.77%

* Annualized

Return Ranking - Calendar

Period SHPAX Return Category Return Low Category Return High Rank in Category (%)
2023 -5.6% -12.6% 19.0% 93.83%
2022 -4.0% -53.9% 3.2% 10.32%
2021 12.3% -39.6% 24.2% 17.42%
2020 -9.2% -13.6% 178.2% 99.34%
2019 11.2% 3.8% 63.8% 94.07%

Total Return Ranking - Trailing

Period SHPAX Return Category Return Low Category Return High Rank in Category (%)
YTD 6.2% -25.7% 27.3% 61.73%
1 Yr 10.6% -25.7% 33.3% 50.62%
3 Yr 4.3%* -34.8% 14.2% 27.10%
5 Yr 8.9%* -6.6% 16.1% 45.65%
10 Yr 6.6%* -0.5% 13.3% 74.77%

* Annualized

Total Return Ranking - Calendar

Period SHPAX Return Category Return Low Category Return High Rank in Category (%)
2023 -0.4% -12.6% 19.0% 82.72%
2022 2.0% -53.9% 3.7% 3.23%
2021 16.7% -33.9% 26.0% 20.00%
2020 3.6% -0.7% 180.6% 98.68%
2019 21.2% 4.6% 63.8% 80.74%

NAV & Total Return History


SHPAX - Holdings

Concentration Analysis

SHPAX Category Low Category High SHPAX % Rank
Net Assets 12.1 M 7.41 M 47.2 B 87.65%
Number of Holdings 33 25 420 93.21%
Net Assets in Top 10 5.03 M 2.19 M 22.7 B 87.65%
Weighting of Top 10 41.65% 17.8% 78.7% 74.07%

Top 10 Holdings

  1. REGENERON PHARM 5.35%
  2. CENCORA INC 5.00%
  3. MCKESSON CORP 4.53%
  4. AMGEN INC 4.51%
  5. THE CIGNA GROUP 3.81%
  6. CARDINAL HEALTH 3.77%
  7. ELEVANCE HEALTH 3.77%
  8. TENET HEALTHCARE 3.71%
  9. THERMO FISHER 3.62%
  10. INTUITIVE SURGIC 3.57%

Asset Allocation

Weighting Return Low Return High SHPAX % Rank
Stocks
99.19% 89.34% 106.13% 30.86%
Cash
1.07% 0.00% 34.44% 64.81%
Preferred Stocks
0.00% 0.00% 7.86% 47.53%
Other
0.00% -22.99% 23.31% 53.09%
Convertible Bonds
0.00% 0.00% 0.37% 29.30%
Bonds
0.00% 0.00% 12.39% 34.57%

Stock Sector Breakdown

Weighting Return Low Return High SHPAX % Rank
Healthcare
100.00% 59.26% 100.00% 17.20%
Utilities
0.00% 0.00% 0.00% 24.84%
Technology
0.00% 0.00% 22.69% 31.85%
Real Estate
0.00% 0.00% 5.89% 28.66%
Industrials
0.00% 0.00% 7.02% 30.57%
Financial Services
0.00% 0.00% 1.60% 47.77%
Energy
0.00% 0.00% 0.00% 24.84%
Communication Services
0.00% 0.00% 9.11% 28.03%
Consumer Defense
0.00% 0.00% 25.73% 33.76%
Consumer Cyclical
0.00% 0.00% 1.92% 30.57%
Basic Materials
0.00% 0.00% 7.16% 52.87%

Stock Geographic Breakdown

Weighting Return Low Return High SHPAX % Rank
US
99.19% 69.36% 104.41% 22.84%
Non US
0.00% 0.00% 27.72% 66.05%

SHPAX - Expenses

Operational Fees

SHPAX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 2.75% 0.08% 4.28% 9.26%
Management Fee 1.25% 0.03% 1.25% 98.77%
12b-1 Fee 0.40% 0.00% 1.00% 58.97%
Administrative Fee N/A 0.03% 0.25% 62.22%

Sales Fees

SHPAX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load 5.75% 3.50% 5.75% 33.33%
Deferred Load N/A 1.00% 5.00% N/A

Trading Fees

SHPAX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 1.00% 1.00% 8.33%

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

SHPAX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 19.00% 0.00% 238.00% 12.32%

SHPAX - Distributions

Dividend Yield Analysis

SHPAX Category Low Category High SHPAX % Rank
Dividend Yield 0.00% 0.00% 6.24% 53.70%

Dividend Distribution Analysis

SHPAX Category Low Category High Category Mod
Dividend Distribution Frequency Annual Annual Annual Annual

Net Income Ratio Analysis

SHPAX Category Low Category High SHPAX % Rank
Net Income Ratio -1.08% -2.54% 1.85% 89.68%

Capital Gain Distribution Analysis

SHPAX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Semi-Annually Annually

Distributions History

View More +

SHPAX - Fund Manager Analysis

Managers

Robert Stimpson


Start Date

Tenure

Tenure Rank

Jan 18, 2019

3.37

3.4%

Robert D. Stimpson, CFA, CMT. Mr. Stimpson is Co-Chief Investment Officer and a Portfolio Manager at Oak Associates, which he joined in 2001. Prior to joining Oak Associates in 2001, Mr. Stimpson earned an MBA from Emory University. Previously, Mr. Stimpson worked as an Equity Market Analyst for I.D.E.A., ltd and for Merrill Lynch as a Financial Consultant. He has been with the investment industry since 1997. In addition to the CFA designation, Mr. Stimpson holds the CMT charter from the Market Technicians Association.

Tenure Analysis

Category Low Category High Category Average Category Mode
0.02 24.72 7.87 0.25